Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cardinal Health

Is Cardinal Health Stock Underperforming the S&P 500?

While Cardinal Health has considerably underperformed the S&P 500 recently, analysts remain highly optimistic about the stock’s prospects.

Barchart

3 Dividend Aristocrats on Sale: Oversold, High Quality, and Built to Last

Three oversold Dividend Aristocrats rated ‘Buy’ by Wall Street—rare bargains offering income, stability, and rebound potential.

Barchart

Stock Market Rallies Amid Shifts Despite Hot Inflation; Amazon, CoreWeave In Focus: Weekly Review

The stock market had a strong week despite hot inflation, but with shifts underneath. Amazon jumped on a grocery delivery push.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Cardinal Health Boosts Specialty Presence With Solaris Health Acquisition, Lifts Profit Outlook

Cardinal Health Inc. (NYSE:CAH) shares fell Tuesday after the company reported mixed fourth-quarter results and announced a $1.9 billion deal to acquire Solaris Health.

Benzinga

Inflation Report: Consumer Prices Up 2.7% Annually, Meeting Expectations

September S&P 500 E-Mini futures (ESU25) are up +0.06%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.02% this morning as investors refrained from making big bets ahead of key U.S. inflation data that could reshape expectations for Federal Reserve rate cuts.

Barchart

How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug. 12.

Benzinga

Do Wall Street Analysts Like Cardinal Health Stock?

Cardinal Health has outperformed the broader market over the past year, and analysts maintain a strongly bullish outlook on its future prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

After earnings fell by $300 million, Cardinal Health’s CEO went ‘ruthless’ to turn it around—and he says workers backed him because ‘people want to win’

Jason Hollar, the Gen X boss of the $38 billion Fortune 500 healthcare giant, overhauled the business—and he says employees were also over being "frustrated that we weren't succeeding."

Fortune

Stock Market's Twists And Turns Put Investors In Place To Profit

Mutual fund investors got thrills from the stock market in the second quarter. The S&P 500 stormed back to new highs.

Investors Business Daily

3 Overlooked Dividend Aristocrats To Buy in 2025

These three dividend companies all share one common trait: strong earnings growth and rising cash flow.

Barchart

3 Under-The-Radar Dividend Aristocrats Set to Breakout in Q3

These three dividend companies all share one commonality: near-perfect buy ratings and breakout potential.

Barchart

3 Dirt-Cheap Dividend Aristocrats About to Explode Higher

These buy-rated Dividend Aristocrats are trading at rare discounts, offering strong yields, bullish ratings, and potential long-term upside.

Barchart

3 Dividend Aristocrats With Explosive Earnings and Bulletproof Payouts

Discover 3 Dividend Aristocrats with high earnings growth, low payout ratios, and strong analyst ratings: perfect for long-term income investors.

Barchart

Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt

While the market has rallied off its April lows, uncertainty continues to dominate investor sentiment. To avoid the volatility, consider these three stocks.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

3 Dividend Aristocrats Quietly Dominating The Market in 2025

These three dividend stocks easily beat the S&P 500's return in 2025 while offering predictable earnings and dividend growth.

Barchart

Cardinal Health Stock Outlook: Is Wall Street Bullish or Bearish?

Cardinal Health has delivered robust gains over the past year, outperforming the broader market, and analysts are highly bullish on its outlook.

Barchart

Earnings Just Sent This Healthcare Stock to New Record Highs

Cardinal Health (CAH) rallied to a new record high on Thursday and closed the day 3% higher. Cardinal Health rallied after its release of positive fiscal Q3 earnings results and a hike in guidance for the full year. The company remains in a long-term 3-year uptrend. Company Description: Cardinal Health...

Barchart

What You Need To Know Ahead of Cardinal Health's Earnings Release

Cardinal Health is scheduled to announce its third-quarter results next month, with analysts anticipating a single-digit earnings growth.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Cardinal Health Has a String of New Highs

Summary Cardinal Health (CAH) shows strong technical buy signals, with a 3.95% gain since the Trend Seeker buy signal on 3/18 and consistent price appreciation. The company operates globally, providing a wide range of healthcare services and products, including pharmaceuticals, medical supplies, and radiopharmaceuticals. Barchart's technical indicators highlight CAH's positive...

Barchart

Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health has surpassed the broader healthcare sector’s performance over the past year, and analysts are expressing continued confidence in its growth potential.

Barchart

Are Wall Street Analysts Predicting Cardinal Health Stock Will Climb or Sink?

Cardinal Health has observed a notable surge in stock prices recently and received several ratings upgrades shifting the consensus to a "Strong Buy."

Barchart

What to Expect From Cardinal Health's Next Quarterly Earnings Report

Cardinal Health is expected to release its fiscal 2025 second-quarter earnings this month, and analysts project a single-digit profit decline.

Investors Business Daily

Cardinal Health Sees Relative Strength Rating Climb To 74

Cardinal Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Barchart

Is Cardinal Health Stock Underperforming the Dow?

Cardinal Health has underperformed the Dow Jones Industrial Average over the past year, yet analysts remain optimistic about the stock’s prospects.

Investors Business Daily

Stocks With Rising Relative Strength: Cardinal Health

Cardinal Health shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.